Raffa G, La Franca E, Lachina C, Palmeri A, Kowalewski M, Lebowitz S
Front Cardiovasc Med. 2022; 9:853582.
PMID: 35783828
PMC: 9242021.
DOI: 10.3389/fcvm.2022.853582.
Affronti A, Pruna-Guillen R, Sandoval E, Pereda D, Alcocer J, Castella M
J Clin Med. 2021; 10(19).
PMID: 34640415
PMC: 8509570.
DOI: 10.3390/jcm10194397.
Song B, Dong R
Medicine (Baltimore). 2016; 95(2):e2326.
PMID: 26765408
PMC: 4718234.
DOI: 10.1097/MD.0000000000002326.
Pandian N, Rowin E, Gonzalez A, Maron M
Echo Res Pract. 2015; 2(1):E1-7.
PMID: 26693314
PMC: 4676468.
DOI: 10.1530/ERP-15-0009.
Zaidi Q, Zaky H, Aljassim O
J Saudi Heart Assoc. 2013; 21(3):165-7.
PMID: 23960567
PMC: 3727354.
DOI: 10.1016/j.jsha.2009.06.006.
Hypertrophic Cardiomyopathy in a Young Adult with RV Aneurysm: Report of a Rare Finding and Review of the Literature.
Abdel-Razek A, Lee L, Tozzi R
Heart Views. 2012; 12(3):112-7.
PMID: 22567198
PMC: 3345142.
DOI: 10.4103/1995-705X.95067.
Management of hypertrophic cardiomyopathy in children.
Seggewiss H, Rigopoulos A
Paediatr Drugs. 2003; 5(10):663-72.
PMID: 14510624
DOI: 10.2165/00148581-200305100-00002.
Hypertrophic obstructive cardiomyopathy: alternative therapeutic options.
Lakkis N, Kleiman N, Killip D, Spencer 3rd W
Clin Cardiol. 1997; 20(5):417-8.
PMID: 9134270
PMC: 6655986.
DOI: 10.1002/clc.4960200503.
Short term reduction of left ventricular mass in primary hypertrophic cardiomyopathy by octreotide injections.
Gunal A, Isik A, Celiker H, Eren O, Celebi H, Gunal S
Heart. 1996; 76(5):418-21.
PMID: 8944587
PMC: 484573.
DOI: 10.1136/hrt.76.5.418.
DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience.
Slade A, Sadoul N, Shapiro L, Chojnowska L, Simon J, Saumarez R
Heart. 1996; 75(1):44-9.
PMID: 8624871
PMC: 484221.
DOI: 10.1136/hrt.75.1.44.
Dual chamber pacing for hypertrophic obstructive cardiomyopathy: has its time come?.
Nishimura R, Danielson G
Br Heart J. 1993; 70(4):301-3.
PMID: 8217436
PMC: 1025323.
DOI: 10.1136/hrt.70.4.301.
